Driving with a neurodegenerative disorder: an overview of the current literature

por Jacobs, Milou, Hart, Ellen P., Roos, Raymund A. C.
Publicado 2017

A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial partici...

por Prins, Samantha, Zhuparris, Ahnjili, Hart, Ellen P., Doll, Robert-Jan, Groeneveld, Geert Jan
Publicado 2021

Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine

por Bakker, Charlotte, van der Aart, Jasper, Hart, Ellen P., Klaassen, Erica S., Bergmann, Kirsten R., van Esdonk, Michiel J., Kay, Denis G., Groeneveld, Geert Jan
Publicado 2020

Quantification of tremor using consumer product accelerometry is feasible in patients with essential tremor and Parkinson’s disease: a comparative study

por van Brummelen, Emilie M. J., Ziagkos, Dimitrios, de Boon, Wadim M. I., Hart, Ellen P., Doll, Robert J., Huttunen, Teppo, Kolehmainen, Petteri, Groeneveld, Geert Jan
Publicado 2020

Reduced functional brain connectivity prior to and after disease onset in Huntington's disease()()

por Dumas, Eve M., van den Bogaard, Simon J.A., Hart, Ellen P., Soeter, Roelof P., van Buchem, Mark A., van der Grond, Jeroen, Rombouts, Serge A.R.B., Roos, Raymund A.C.
Publicado 2013

Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M(1) receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending...

por Bakker, Charlotte, Tasker, Tim, Liptrot, Jan, Hart, Ellen P., Klaassen, Erica S., Doll, Robert Jan, Brown, Giles A., Brown, Alastair, Congreve, Miles, Weir, Malcolm, Marshall, Fiona H., Cross, David M., Groeneveld, Geert Jan, Nathan, Pradeep J.
Publicado 2021

Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M(1)‐acetylcholine receptor agonist: A randomized cross‐over trial

por Bakker, Charlotte, Prins, Samantha, Liptrot, Jan, Hart, Ellen P., Klaassen, Erica S., Brown, Giles A., Brown, Alastair, Congreve, Miles, Weir, Malcolm, Marshall, Fiona H., Stevens, Jasper, Cross, David M., Tasker, Tim, Nathan, Pradeep J., Groeneveld, Geert Jan
Publicado 2021

First‐in‐man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M(1)‐receptor partial agonist for the treatment of dementias...

por Bakker, Charlotte, Tasker, Tim, Liptrot, Jan, Hart, Ellen P., Klaassen, Erica S., Prins, Samantha, van der Doef, Thalia F., Brown, Giles A., Brown, Alastair, Congreve, Miles, Weir, Malcolm, Marshall, Fiona H., Cross, David M., Groeneveld, Geert Jan, Nathan, Pradeep J.
Publicado 2021

Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study

por van Diemen, Marcus P.J., Hart, Ellen P., Abbruscato, Anthony, Mead, Liz, van Beelen, Ilse, Bergheanu, Sandrin C., Hameeteman, Pieter W., Coppen, Emma, Winder, Jessica Y., Moerland, Matthijs, Kan, Hermien, van der Grond, Jeroen, Webb, Andrew, Roos, Raymund A.C., Groeneveld, Geert Jan
Publicado 2020

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease

por Stout, Julie C, Jones, Rebecca, Labuschagne, Izelle, O'Regan, Alison M, Say, Miranda J, Dumas, Eve M, Queller, Sarah, Justo, Damian, Santos, Rachelle Dar, Coleman, Allison, Hart, Ellen P, Dürr, Alexandra, Leavitt, Blair R, Roos, Raymund A, Langbehn, Doug R, Tabrizi, Sarah J, Frost, Chris
Publicado 2012